Tearsheet

National Healthcare (NHC)


Market Price (12/4/2025): $137.25 | Market Cap: $2.1 Bil
Sector: Health Care | Industry: Health Care Facilities

National Healthcare (NHC)


Market Price (12/4/2025): $137.25
Market Cap: $2.1 Bil
Sector: Health Care
Industry: Health Care Facilities

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.4%, Dividend Yield is 2.0%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.3%, FCF Yield is 7.8%
Trading close to highs
Dist 52W High is -0.2%, Dist 3Y High is -0.2%
 
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 12%
  
2 Low stock price volatility
Vol 12M is 28%
  
3 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, and Remote Patient Monitoring.
  
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.4%, Dividend Yield is 2.0%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.3%, FCF Yield is 7.8%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 12%
2 Low stock price volatility
Vol 12M is 28%
3 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, and Remote Patient Monitoring.
4 Trading close to highs
Dist 52W High is -0.2%, Dist 3Y High is -0.2%

Valuation, Metrics & Events

NHC Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

Here are five key points explaining why National Healthcare (NHC) stock likely moved by approximately 22% between August 31, 2025, and December 4, 2025:

1. Strong Third Quarter 2025 Earnings Performance: National HealthCare Corporation reported robust third-quarter 2025 financial results on November 7, 2025, with net operating revenues increasing by 12.5% compared to the prior year. Adjusted net income for the quarter also saw a significant rise of 24.3%, indicating strong operational performance.

2. Positive Contribution from Strategic Acquisitions: The strategic acquisition of White Oak Management, Inc., completed on August 1, 2024, continued to positively impact NHC's financial results in 2025, contributing to revenue growth in both the second and third quarters. The acquisition added 22 healthcare operations to NHC's portfolio, enhancing its scale and revenue base.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
NHC Return-21%5%-9%61%19%30%88%
Peers Return13%5%9%-1%-12%-15%-4%
S&P 500 Return16%27%-19%24%23%16%112%

Monthly Win Rates [3]
NHC Win Rate25%42%42%67%58%60% 
Peers Win Rate15%15%15%10%6%25% 
S&P 500 Win Rate58%75%42%67%75%70% 

Max Drawdowns [4]
NHC Max Drawdown-34%-4%-13%-12%-5%-16% 
Peers Max Drawdown-16%-0%-4%-5%-13%-16% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: ACHC, AMTU, AVG, MCTA, SRTA.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/3/2025 (YTD)

How Low Can It Go

Unique KeyEventNHCS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-33.8%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven51.0%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven266 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-35.3%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven54.5%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven1362 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-25.0%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven33.3%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven205 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-37.9%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven60.9%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven1958 days1480 days

Compare to ACHC, AMTU, AVG, MCTA, SRTA


In The Past

National Healthcare's stock fell -33.8% during the 2022 Inflation Shock from a high on 3/18/2021. A -33.8% loss requires a 51.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About National Healthcare (NHC)

Better Bets than National Healthcare (NHC)

Latest Trefis Analyses

Trade Ideas

Select past ideas related to NHC. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
4.1%4.1%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-9.8%-9.8%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
6.0%6.0%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
9.7%9.7%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
6.2%6.2%-5.1%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
4.1%4.1%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-9.8%-9.8%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
6.0%6.0%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
9.7%9.7%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
6.2%6.2%-5.1%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for National Healthcare

Peers to compare with:

Financials

NHCACHCAMTUAVGMCTASRTAMedian
NameNational.Acadia H.Amatuhi Anew Hea.Charming.Strata C. 
Mkt Price137.6814.69---4.4414.69
Mkt Cap2.11.3----1.7
Rev LTM1,5013,266---2541,501
Op Inc LTM124444----24124
FCF LTM147-347----20-20
FCF 3Y Avg104-252----32-32
CFO LTM181335---1181
CFO 3Y Avg133308----18133

Growth & Margins

NHCACHCAMTUAVGMCTASRTAMedian
NameNational.Acadia H.Amatuhi Anew Hea.Charming.Strata C. 
Rev Chg LTM22.1%4.6%---6.7%6.7%
Rev Chg 3Y Avg11.9%9.0%---36.5%11.9%
Rev Chg Q12.5%4.4%---4.2%4.4%
QoQ Delta Rev Chg LTM2.9%1.1%---1.1%1.1%
Op Mgn LTM8.3%13.6%----9.6%8.3%
Op Mgn 3Y Avg6.2%16.2%----22.0%6.2%
QoQ Delta Op Mgn LTM0.3%-1.0%---3.0%0.3%
CFO/Rev LTM12.1%10.3%---0.5%10.3%
CFO/Rev 3Y Avg10.2%10.2%----8.9%10.2%
FCF/Rev LTM9.8%-10.6%----7.7%-7.7%
FCF/Rev 3Y Avg7.9%-7.8%----14.6%-7.8%

Valuation

NHCACHCAMTUAVGMCTASRTAMedian
NameNational.Acadia H.Amatuhi Anew Hea.Charming.Strata C. 
Mkt Cap2.11.3----1.7
P/S1.30.7----1.0
P/EBIT13.08.2----10.6
P/E18.620.9----19.7
P/CFO10.46.7----8.5
Total Yield7.4%4.8%----6.1%
Dividend Yield2.0%0.0%----1.0%
FCF Yield 3Y Avg6.7%-7.6%-----0.5%
D/E0.11.1----0.6
Net D/E-0.11.0----0.5

Returns

NHCACHCAMTUAVGMCTASRTAMedian
NameNational.Acadia H.Amatuhi Anew Hea.Charming.Strata C. 
1M Rtn13.7%-31.1%----12.9%-12.9%
3M Rtn23.3%-37.0%---7.0%7.0%
6M Rtn33.4%-35.0%-----0.8%
12M Rtn12.5%-65.2%-----26.4%
3Y Rtn149.4%-83.2%----33.1%
1M Excs Rtn13.8%-31.0%----12.9%-12.9%
3M Excs Rtn14.8%-43.2%---0.9%0.9%
6M Excs Rtn18.7%-49.7%-----15.5%
12M Excs Rtn-1.0%-77.4%-----39.2%
3Y Excs Rtn72.9%-155.4%-----41.2%

Financials

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Inpatient services957912932931894
Homecare and hospice services132129975255
All Other5345454648
Total1,1421,0861,0741,028996


Operating Income by Segment
$ Mil20242023202220212020
Inpatient services4210615852
Homecare and hospice services24221923
All Other-100-30-11-6
Total5732514849


Price Behavior

Short Interest

Short Interest: As Of Date11142025
Short Interest: Shares Quantity304,167
Short Interest: % Change Since 103120253.4%
Average Daily Volume63,423
Days-to-Cover Short Interest4.80
Basic Shares Quantity15,484,464
Short % of Basic Shares2.0%

SEC Filings

Expand for More

Report DateFiling DateFiling
93020251106202510-Q 9/30/2025
6302025807202510-Q 6/30/2025
3312025508202510-Q 3/31/2025
12312024228202510-K 12/31/2024
93020241107202410-Q 9/30/2024
6302024808202410-Q 6/30/2024
3312024509202410-Q 3/31/2024
12312023216202410-K 12/31/2023
93020231102202310-Q 9/30/2023
6302023803202310-Q 6/30/2023
3312023504202310-Q 3/31/2023
12312022217202310-K 12/31/2022
93020221103202210-Q 9/30/2022
6302022804202210-Q 6/30/2022
3312022505202210-Q 3/31/2022
12312021218202210-K 12/31/2021